Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial

Abstract

BackgroundOpen transthoracic oesophagectomy is the standard treatment for infracarinal resectable oesophageal carcinomas, although it is associated with high mortality and morbidity rates of 2 to 10% and 30 to 50%, respectively, for both the abdominal and thoracic approaches. The worldwide popularity of laparoscopic techniques is based on promising results, including lower postoperative morbidity rates, which are related to the reduced postoperative trauma. We hypothesise that the laparoscopic abdominal approach (laparoscopic gastric mobilisation) in oesophageal cancer surgery will decrease the major postoperative complication rate due to the reduced surgical trauma.Methods/DesignThe MIRO trial is an open, controlled, prospective, randomised multicentre phase III trial. Patients in study arm A will receive laparoscopic-assisted oesophagectomy, i.e., a transthoracic oesophagectomy with two-field lymphadenectomy and laparoscopic gastric mobilisation. Patients in study arm B will receive the same procedure, but with the conventional open abdominal approach. The primary objective of the study is to evaluate the major postoperative 30-day morbidity. Secondary objectives are to assess the overall 30-day morbidity, 30-day mortality, 30-day pulmonary morbidity, disease-free survival, overall survival as well as quality of life and to perform medico-economic analysis. A total of 200 patients will be enrolled, and two safety analyses will be performed using 25 and 50 patients included in arm A.DiscussionPostoperative morbidity remains high after oesophageal cancer surgery, especially due to major pulmonary complications, which are responsible for 50% of the postoperative deaths. This study represents the first randomised controlled phase III trial to evaluate the benefits of the minimally invasive approach with respect to the postoperative course and oncological outcomes in oesophageal cancer surgery.Trial RegistrationNCT00937456 (ClinicalTrials.gov)

A New Clinical Scoring System to Define Pneumonia following Esophagectomy for Cancer

“…Hence, studies on resection techniques in esophageal cancer surgery focus mainly on a reduction of morbidity, particularly respiratory complications and pneumonia. It is remarkable that these studies use different definitions of pneumonia [18,21] or fail to provide a definition altogether [22,23,24,25,26]. Consequently, the reported pneumonia rates vary widely.…”

Multimodal Treatment for Cancer of the Esophagus

“…These limitations pave the way for the occurrence of unknown interactions and confounding variables. Currently, there are two diferent clinical trials comparing E to MIE patients, namely the French MIRO trial [52] and the British ROMIRO trail [53]. Still, the study that we conducted is the most extensive comparative efectiveness research of MIE assessing long-term survival.…”

Recent management of esophago-gastric adenocarcinoma

“…The comparison of laparoscopic approach and open for the abdominal time is the subject of a French Study (MIRO-Trial), which shows a clear benefit for this hybrid minimally invasive approach [18]. Table 2 resumes the treatment for junction tumor according to the Siewert Classification.…”